ArticleAmerican journal of translational research2021
Differential expressions of carcinoembryonic antigen and squamous cell carcinoma antigen in patients with advanced cervical cancer undergoing chemotherapy.
Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- Observations of the effectiveness, dosage, and prognosis of intensity-modulated radiation therapy under ultrasonic guidance for cervical cancer patients.Technology and health care : official journal of the European Society for Engineering and Medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCervical cancer is a malignant tumor commonly found in women. This study was conducted to discuss the differential expression of carcinoembryonic antigen (CEA) and squamous cell carcinoma antigen (SCCA) in patients with advanced cervical cancer undergoing various chemotherapies and their effects on patient safety.
methodsA total of 65 patients admitted to our hospital with advanced cervical cancer were included as the study subjects and were divided into two groups based on the chemotherapy they received: control group (n = 31) and observation group (n = 34). After two cycles of systemic (IV) chemotherapy in the control group and intra-arterial infusion chemotherapy in the observation group, the two groups were compared for treatment efficacy.
resultsAfter chemotherapy, the effective rate was 76.47% in the observation group and 48.39% in the control group (
conclusionIn patients with advanced cervical cancer, intra-arterial infusion chemotherapy can improve the efficacy and short-and long-term survival, and reduce the serum VEGF level, blood flow in the tumor, metastasis, and reoccurrence.
Indexed as
Identifiers
34786117PMC8581896W3213035028What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.